CAG repeat length in androgen receptor gene is not associated with amyotrophic lateral sclerosis

Eur J Neurol. 2012 Oct;19(10):1373-5. doi: 10.1111/j.1468-1331.2011.03646.x. Epub 2012 Jan 10.

Abstract

Background: Epidemiological and clinical studies show higher prevalence of amyotrophic lateral sclerosis (ALS) in males than in females and more severe lesions in androgen receptor (AR)-expressing tissues. The AR gene contains a polymorphic CAG trinucleotide repeat, whose expansion over a certain threshold is toxic to motor neurons, causing spinal and bulbar muscular atrophy (SBMA).

Purpose and methods: We tested the hypothesis that the AR CAG repeat linked to SBMA is a risk factor for ALS. We analyzed AR CAG expansions in 336 patients with ALS and 100 controls.

Results: We found a negative association of AR CAG expansions with ALS susceptibility, clinical presentation, and survival.

Conclusions: Our findings do not support a role of the AR CAG repeat length in ALS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Amyotrophic Lateral Sclerosis / genetics*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Receptors, Androgen / genetics*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Trinucleotide Repeat Expansion / genetics*
  • Young Adult

Substances

  • Receptors, Androgen